Abstract
Any important aggression toward our bodies leads to a complex systemic inflammatory response that can be expressed by biomarkers. Thus biomarkers can help us to diagnose and manage the initial aggression. Application of biomarkers to ventilator-associated pneumonia (VAP) has two additional difficulties: the lack of universal consensus regarding the diagnostic criteria and the difficulty of discriminating the inflammatory response secondary to VAP in a context (that of ventilated critical-care patients) in which there is already a nonspecific inflammatory response. However, biomarkers have been studied in VAP and promising results have been achieved concerning diagnosis and follow-up. The most studied biomarkers have been C-reactive protein, procalcitonin, sTREM-1 and cytokines. Nevertheless, heterogeneicity of results makes difficult to apply conclusions to the general ICU population. Authors differ in VAP diagnosis criteria and in the selection of the control group (in some studies other infections different from VAP cause changes in serum biomarkers). The true diagnostic value of these substances lies in reinforcing the habitual clinical algorithm; when interpreting the results, we should take into consideration all the factors that may modify the inflammatory response.
Keywords: Biomarkers, ventilator-associated pneumonia, C-reactive protein, procalcitonin, sTREM-1, cytokines
Current Respiratory Medicine Reviews
Title: Systemic Inflammatory Response as a Risk and Prognosis Factor in Ventilator-Associated Pneumonia
Volume: 6 Issue: 1
Author(s): Paula Ramirez, Miquel Ferrer and Antoni Torres
Affiliation:
Keywords: Biomarkers, ventilator-associated pneumonia, C-reactive protein, procalcitonin, sTREM-1, cytokines
Abstract: Any important aggression toward our bodies leads to a complex systemic inflammatory response that can be expressed by biomarkers. Thus biomarkers can help us to diagnose and manage the initial aggression. Application of biomarkers to ventilator-associated pneumonia (VAP) has two additional difficulties: the lack of universal consensus regarding the diagnostic criteria and the difficulty of discriminating the inflammatory response secondary to VAP in a context (that of ventilated critical-care patients) in which there is already a nonspecific inflammatory response. However, biomarkers have been studied in VAP and promising results have been achieved concerning diagnosis and follow-up. The most studied biomarkers have been C-reactive protein, procalcitonin, sTREM-1 and cytokines. Nevertheless, heterogeneicity of results makes difficult to apply conclusions to the general ICU population. Authors differ in VAP diagnosis criteria and in the selection of the control group (in some studies other infections different from VAP cause changes in serum biomarkers). The true diagnostic value of these substances lies in reinforcing the habitual clinical algorithm; when interpreting the results, we should take into consideration all the factors that may modify the inflammatory response.
Export Options
About this article
Cite this article as:
Ramirez Paula, Ferrer Miquel and Torres Antoni, Systemic Inflammatory Response as a Risk and Prognosis Factor in Ventilator-Associated Pneumonia, Current Respiratory Medicine Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339810790820395
DOI https://dx.doi.org/10.2174/157339810790820395 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Rise of Carbapenem-Resistant Acinetobacter baumannii
Current Pharmaceutical Design Indications for Surgery and Operative Techniques in Infective Endocarditis in the Present Day
Infectious Disorders - Drug Targets A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
Current Drug Metabolism Myocardial Infarction in Systemic Lupus Erythematosus – the Sex-Specific Risk Profile
Current Pharmaceutical Design Development and Validation of a UV-Spectrophotometric Method for Determination of Flucloxacillin Sodium in Capsules
Current Pharmaceutical Analysis Vaccines and Photodynamic Therapies for Oral Microbial-Related Diseases
Current Drug Metabolism Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise
Current Psychopharmacology Cardiovascular Disease in Antiphospholipid Syndrome
Current Vascular Pharmacology In Vitro Synergistic Action of Certain Combinations of Gentamicin and Essential Oils
Current Medicinal Chemistry Systemic Fungal Infections Caused by Candida Species: Epidemiology, Infection Process and Virulence Attributes
Current Drug Targets Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus
Current Cardiology Reviews Editorial: Bioengineering, Clinical and Therapeutical Trends in Transcatheter Aortic Valve Implantation
Current Pharmaceutical Design Methods to Measure Target Site Penetration of Antibiotics in Critically Ill Patients
Current Clinical Pharmacology Drug-Induced Thromboembolic Events in Patients with Malignancy
Cardiovascular & Hematological Disorders-Drug Targets Riboswitches as Potential Targets for the Development of Anti-Biofilm Drugs
Current Topics in Medicinal Chemistry Complex Atheromatosis of the Aortic Arch in Cerebral Infarction
Current Cardiology Reviews Drug Delivery Systems Based on Titania Nanotubes and Active Agents for Enhanced Osseointegration of Bone Implants
Current Medicinal Chemistry Biosynthesis and Genetic Engineering of Lipopeptide Antibiotics Related to Daptomycin
Current Topics in Medicinal Chemistry Value of Real Time Three Dimensional Transesophageal Echocardiography in General Cardiology Practice
Recent Patents on Medical Imaging Synthesis, Structure and Antibacterial Evaluation of Some N-substituted 3-amino-5-hydroxy-4-phenyl-1H-pyrazole-1-carboxamides
Medicinal Chemistry